CN107198727A - 一种美容养颜活血调经的药物组合物及其制备方法 - Google Patents
一种美容养颜活血调经的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN107198727A CN107198727A CN201710375035.7A CN201710375035A CN107198727A CN 107198727 A CN107198727 A CN 107198727A CN 201710375035 A CN201710375035 A CN 201710375035A CN 107198727 A CN107198727 A CN 107198727A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- isoflavones
- blood circulation
- beautifying face
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 43
- 230000005906 menstruation Effects 0.000 title claims abstract description 38
- 230000001737 promoting effect Effects 0.000 title claims abstract description 28
- 230000017531 blood circulation Effects 0.000 title claims abstract description 26
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 25
- 239000006210 lotion Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 65
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 65
- 150000002515 isoflavone derivatives Chemical class 0.000 claims abstract description 43
- 244000045195 Cicer arietinum Species 0.000 claims abstract description 27
- 235000010523 Cicer arietinum Nutrition 0.000 claims abstract description 27
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims abstract description 22
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 19
- 240000007926 Ocimum gratissimum Species 0.000 claims abstract description 19
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 19
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 18
- 235000010254 Jasminum officinale Nutrition 0.000 claims abstract description 18
- 240000005385 Jasminum sambac Species 0.000 claims abstract description 18
- 235000010676 Ocimum basilicum Nutrition 0.000 claims abstract description 18
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 17
- 235000005881 Calendula officinalis Nutrition 0.000 claims abstract description 17
- 240000001592 Amaranthus caudatus Species 0.000 claims abstract description 16
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims abstract description 16
- 241000167550 Centella Species 0.000 claims abstract description 16
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 16
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 16
- 244000019459 Cynara cardunculus Species 0.000 claims abstract description 16
- 235000019106 Cynara scolymus Nutrition 0.000 claims abstract description 16
- 235000003230 Helianthus tuberosus Nutrition 0.000 claims abstract description 16
- 241000531434 Lamprocapnos spectabilis Species 0.000 claims abstract description 16
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 16
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 16
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 16
- 235000012735 amaranth Nutrition 0.000 claims abstract description 16
- 239000004178 amaranth Substances 0.000 claims abstract description 16
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 16
- 240000005342 Hypericum chinense Species 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- 239000003814 drug Substances 0.000 claims description 35
- 239000000843 powder Substances 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 238000001471 micro-filtration Methods 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000000287 crude extract Substances 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 3
- 238000004042 decolorization Methods 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 230000035784 germination Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 150000002605 large molecules Chemical class 0.000 claims description 3
- 229920002521 macromolecule Polymers 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 230000029219 regulation of pH Effects 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 241001252564 Chrysopsis Species 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical group [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 claims 1
- 210000002221 olecranon process Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 25
- 201000010099 disease Diseases 0.000 abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 14
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 210000004185 liver Anatomy 0.000 abstract description 12
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 21
- 208000037093 Menstruation Disturbances Diseases 0.000 description 14
- 206010027339 Menstruation irregular Diseases 0.000 description 12
- 229940079593 drug Drugs 0.000 description 10
- 241000700159 Rattus Species 0.000 description 8
- 229940011871 estrogen Drugs 0.000 description 8
- 239000000262 estrogen Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 6
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 5
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 229940028334 follicle stimulating hormone Drugs 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229960005309 estradiol Drugs 0.000 description 4
- 229930182833 estradiol Natural products 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000003821 menstrual periods Effects 0.000 description 4
- 230000027758 ovulation cycle Effects 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 244000235659 Rubus idaeus Species 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003416 augmentation Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 235000015810 grayleaf red raspberry Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- -1 It can be seen that Substances 0.000 description 1
- XPPALVZZCMPTIV-ARJAWSKDSA-N Jasmine lactone Chemical compound CC\C=C/CC1CCCC(=O)O1 XPPALVZZCMPTIV-ARJAWSKDSA-N 0.000 description 1
- XPPALVZZCMPTIV-UHFFFAOYSA-N Jasmine lactone Natural products CCC=CCC1CCCC(=O)O1 XPPALVZZCMPTIV-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 235000004072 Ocimum sanctum Nutrition 0.000 description 1
- 240000002837 Ocimum tenuiflorum Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000035175 Oligomenorrhea Diseases 0.000 description 1
- 206010030295 Oligomenorrhoea Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010065951 Retrograde menstruation Diseases 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及中药领域,特别地,涉及一种美容养颜活血调经的药物组合物及其制备方法,所述的药物组合物包括以下重量份数的制备原料:鹰嘴豆异黄酮15‑20份、大豆异黄酮12‑18份、罗勒10‑18份、荷包牡丹10‑18份、刺五加15‑20份、当归15‑20份、白花苋15‑20份、素馨花13‑18份、覆盘子9‑12份、番红花6‑10份、柠檬汁6‑9份、积雪草6‑12份、金盏花6‑12份、黄金菊6‑9份、朝鲜蓟根6‑9份、金钱薄荷6‑10份、金丝桃根2‑5份和甘草8‑20份;该药物组合物在美容养颜活血调经方面具有显著的疗效,能有效的补肾、扶脾、疏肝、调理气血,有效治疗各种月经病,标本兼治,同时达到美容养颜的效果。
Description
技术领域
本发明涉及中药领域,特别地,涉及一种美容养颜活血调经的药物组合物及其制备方法。
背景技术
月经病是指月经周期、经期、经量的异常或伴经色、经质的异常;月经的非生理性停闭或多次伴随月经周期,或于绝经前后所出现的有关症状为特征的一类疾病。以月经周期异常为主的病有月经先期、月经后期、月经先后不定期;以经期异常为主的病有经期延长;以经量异常为主的病有月经过多,月经过少,月经时多时少;经色异常的有经来色淡、经来色紫、经来如黄泥水、月经来如胆水等;经质异常的如经来成块、经来如牛膜片等;非生理性停经的有经闭;伴随月经周期前后出现的病症有痛经、崩漏、逆经、经行吐衄、经行便血、经行身痛、经行发热、经行泄泻、经来浮肿等;绝经前后出现的病症有绝经前后诸症,年未老经水断、年老经水复行、经断复来等。
中医学认为治疗月经不调应先明确病症原因,即可对症施治。治疗月经不调,一般会从补肾、扶脾、疏肝、调理气血着手,中医在于对病症的标本兼治,需要患者根据病情选择使用,不可因为误用西药而耽误就医。中医认为经水出于肾,故调理月经的根本在于补肾。通过调理使得肾气充足,精血旺盛,则月经自然通调。补肾法以填补精血为主。脾的功能是化生血液,补脾胃可以充足身体的血源。扶脾法以健脾升阳为主。而疏肝理气的目的则在于调畅气机,疏通气血,如果气血调和,则月经通调。
市场上有大量治疗月经不调的药物,多数治疗药物都是“治标不治本”。一些药物还容易产生耐药性,一名患者在使用某种药物达一定时间之后就必须换药物品种,才能维持疗效,一些有效的配方只能因人用方,往往病因不对症而效果不佳。因此有必要提供一种药效全面,能针对不同病因使用药物组合物。
月经不调的患者往往带有面部黄褐斑,面色不华以及痤疮,雀斑,眼睑肿胀等症状,对女性的身体健康影响极大,并且往往会使女性容貌变差,自信心越来越低,并伴有一些心理问题,使患者心理上和生理上都受到折磨,然而调经的过程是一个缓慢的过程,一般的药物治疗都是针对月经不调的症状,一般认为在月经调和以后自然能改善气色,达到美容的效果,因此,针对月经不调症状并同时具有美容养颜效果的药物少之又少,因此有必要提供一种能同时达到这两种效果的药物组合物。
发明内容
本发明提供了一种美容养颜活血调经的药物组合物及其制备方法,该药物组合物在美容养颜活血调经方面具有显著的疗效,能有效的补肾、扶脾、疏肝、调理气血,有效治疗各种月经病,标本兼治,同时达到美容养颜的效果,调理女性身体;并且通过本发明药方君臣佐使诸药配合,协同促进,相辅相成,使得药效更好,药物的疗效更加全面,且不易反复,无副作用,没有任何西药或者激素药成分;此外,本发明还提供一种制备该药物组合物的方法。
本发明所述的一种美容养颜活血调经的药物组合物包括以下重量份数的制备原料:
鹰嘴豆异黄酮15-20份、大豆异黄酮12-18份、罗勒10-18份、荷包牡丹10-18份、刺五加15-20份、当归15-20份、白花苋15-20份、素馨花13-18份、覆盘子9-12份、番红花6-10份、柠檬汁6-9份、积雪草6-12份、金盏花6-12份、黄金菊6-9份、朝鲜蓟根6-9份、金钱薄荷6-10份、金丝桃根2-5份和甘草8-20份。
优选的,所述的药物组合物包括以下重量份数的制备原料:
鹰嘴豆异黄酮15份、大豆异黄酮12份、罗勒10份、荷包牡丹10份、刺五加15份、当归15份、白花苋15份、素馨花13份、覆盘子9份、番红花6份、柠檬汁6份、积雪草6份、金盏花6份、黄金菊6份、朝鲜蓟根6份、金钱薄荷6份、金丝桃根2份和甘草8份。
优选的,所述的药物组合物包括以下重量份数的制备原料:
鹰嘴豆异黄酮20份、大豆异黄酮18份、罗勒18份、荷包牡丹18份、刺五加20份、当归20份、白花苋20份、素馨花18份、覆盘子12份、番红花10份、柠檬汁9份、积雪草12份、金盏花12份、黄金菊9份、朝鲜蓟根9份、金钱薄荷10份、金丝桃根5份和甘草20份。
优选的,所述的药物组合物包括以下重量份数的制备原料:
鹰嘴豆异黄酮18份、大豆异黄酮15份、罗勒14份、荷包牡丹14份、刺五加18份、当归18份、白花苋18份、素馨花15份、覆盘子10份、番红花8份、柠檬汁8份、积雪草9份、金盏花9份、黄金菊8份、朝鲜蓟根8份、金钱薄荷8份、金丝桃根3份和甘草14份。
进一步的,所述鹰嘴豆异黄酮的制备方法步骤如下:
步骤一:将鹰嘴豆用水浸泡,在10-20℃下发芽处理3-5天,分离出胚芽,在40-50℃下烘干,粉碎,加入20-50质量倍的体积浓度为55%-85%的乙醇水溶液,混合,在超声功率200-500W条件下,超声10-30min,在水浴温度60-80℃下加热1-2h提取,分离,提取1-6次,合并提取液并过滤,滤液旋转除尽乙醇,得到粗提液;
步骤二:将粗提液装入大孔树脂柱,静置1-3h,先用体积浓度为10%-20%的乙醇水溶液洗去杂质,再用体积浓度为60%-90%乙醇水溶液洗脱,洗脱流速为0.5-2mL/min,收集洗脱液,旋转蒸发,除尽乙醇,得到浓缩液,真空冷冻干燥,得到黄色粉末鹰嘴豆异黄酮。
再进一步的,步骤二所述大孔树脂的型号为AB-8、DM-130、DM301、D101、HP-100、XAD-2或HP-20型。
进一步的,所述大豆异黄酮的制备方法包括以下步骤:
步骤一:将大豆磨碎并进行发酵处理;
步骤二:将大豆的发酵液放入陶瓷膜中膜进行过滤处理,将其中有的菌体、菌落、菌丝体、不可溶型蛋白以及可溶性大分子蛋白等杂质去除,得到微滤透析液;
步骤三:将微滤透析液放入有机脱色膜系统进行脱色处理,然后调节PH后进行浓缩处理,得到大豆异黄酮浓缩液,将大豆异黄酮浓缩液再次调节PH,除去其中可溶蛋白质,最后进行浓缩结晶处理,得到大豆异黄酮结晶块;
步骤四:将得到的大豆异黄酮结晶块放入乙醇后进行润洗处理,然后进行完全干燥处理,得到干燥的大豆异黄酮结晶块,研磨粉碎,得到大豆异黄酮。
再进一步的,所述步骤三中通过柠檬酸和氢氧化钠对微滤透析液和大豆异黄酮浓缩液进行PH调节。
进一步的,所述药物组合物被制成胶囊剂,滴丸剂,散剂,口服液,片剂和颗粒剂。
相应的,本发明药物组合物的制备方法包含下述步骤:
1)称取罗勒、刺五加、当归、覆盘子、朝鲜蓟根和金丝桃根,粉碎,混合均匀,备用;
2)往步骤1)中药粉加入药粉重量6-8倍浓度为60%-70%的乙醇溶液,回流提取1-3次,回流时间为1-2h,合并滤液,保留滤渣,滤液回收乙醇,减压浓缩至55-60℃环境下相对密度为1.20-1.25的浸膏,减压干燥,粉碎后过80-100目筛,得到浸膏细粉;
3)称取荷包牡丹、白花苋、素馨花、番红花、积雪草、金盏花、黄金菊、金钱薄荷和甘草,粉碎,混合均匀,备用;
4)取步骤3)中药粉,加入步骤2)中的滤渣,混合,得到混合物,加入混合物重量4-6倍的蒸馏水,浸泡1-2小时,回流煎煮1-2小时,过滤,再加入混合物重量3-4倍的蒸馏水,回流煎煮0.5-1小时,过滤,合并滤液,减压浓缩至55-60℃环境下相对密度为1.20-1.25的浸膏,加入柠檬汁,减压干燥,粉碎后过80-100目筛,得到浸膏细粉;
5)将鹰嘴豆异黄酮、大豆异黄酮与步骤2)中浸膏细粉和步骤4)中浸膏细粉混合,搅拌均匀,即得本发明药物组合物。
本发明中药配方概述:
鹰嘴豆异黄酮:鹰嘴豆异黄酮对女性健康的影响很大,是具有活性的植物性类雌激素,它能够延迟女性细胞衰老,使皮肤保持弹性、养颜、丰乳、减少骨质丢失,促成骨生成、降血脂、减轻女性更年期综合症状等,鹰嘴豆富含叶酸、钾、镁、磷、锌、铜和维生素B1,还含有一定数量的烟酸、维生素B6、泛酸、钙和纤维,鹰嘴豆在补血、补钙等方面作用明显。
大豆异黄酮:可防治一些和雌激素水平下降有关的疾病,延缓女性衰老、改善更年期症状、骨质疏松、血脂升高、乳腺癌等,异黄酮可与骨细胞上的雌激素受体结合,减少骨质流失,同时增加机体对钙的吸收,增加骨密度;大豆异黄酮的雌激素样作用可使女性皮肤光滑、细腻、柔嫩、富有弹性,焕发青春风采,女性通过补充雌激素激活乳房中的脂肪组织,使游离脂肪定向吸引到乳房,从而达到丰乳的效果;长期补充大豆异黄酮可使体内雌激素维持正常水平,达到改善经期不适的目的。
罗勒:为唇形科罗勒属植物罗勒,又名九层塔、气香草、矮糠、零陵香、光明子等,以全草入药。性温昧辛,有疏风行气、化湿消食、活血、解毒之功能;用于外感头痛、食胀气滞、脘痛、泄泻、月经不调、跌打损伤、蛇虫咬伤、皮肤湿疮、瘾疹痛痒等症的治疗。
荷包牡丹:全草入药,有镇痛、解痉、利尿、调经、散血、和血、除风、消疮毒等功效。
刺五加:其根部和根状茎可入药,炮制方法:春、秋季采挖,去泥土,晒干;《名医别录》认为刺五加有补中,益精等功效;属于补气药,味辛、苦、微甘,性温,归脾、肾、心经;益气健脾,补肾安神,能补肝肾,活血脉。
当归:性温,味甘辛,归心、肝、脾经,补血和血,调经止痛,润燥滑肠,治月经不调,经闭腹痛,症瘕结聚,崩漏,血虚头痛,眩晕,痿痹,肠燥便难,赤痢后重,痈疽疮窃,跌扑损伤。
白花苋:根及花供药用,生用可破血、利湿,炒用补肝肾、强筋骨;辛,性微寒;活血散瘀,清热除湿;主月经不调、血瘀崩漏、经闭等。
素馨花:苦,平,无毒;素馨花中含有芳樟醇,乙酸苯甲酯,苯甲酸(Z)-3-乙烯酯,顺式-茉莉酮,吲哚,素馨内酯及茉莉酮酸甲酯,具有舒肝解郁、行气止痛的功效;素馨花还具有护肤美容之功。
覆盆子:归肝、肾经;收涩药、补肾药;复盆子含有机酸、糖类及少量维生素C和食子酸、β-谷甾醇、复盆子酸;补肝益肾,固精缩尿,明目。
番红花:味甘、微辛,性平;归心、肝经;体轻质润,入血行散;具有活血祛瘀,散郁开结,凉血解毒的功效;主治月经不调,痛经,经闭,产后恶露不行等症状,月经过多及孕妇禁服。
柠檬汁:取新鲜柠檬榨汁,加入少量的柠檬汁可以使药物苦味减少,调节口味,柠檬汁本身具有美容抗氧化功效,能美容养颜,使皮肤更好。
积雪草:味苦、辛,性寒;归肝、脾、肾经,清热利湿,解毒消肿,具有滋补、消炎、愈合伤口、利尿通便和镇定作用,既有抗菌消炎作用,又能美容。
金盏花:金盏菊性味淡平,花、叶有消炎、抗菌作用;根能行气活血,花可凉血、止血;还具有很好的护肤美容作用。
黄金菊:黄金菊有疏风清热,平肝明目,消除头痛,止吐,促进结疤,利消化,柔软皮肤且能缓解感冒引起的肌肉痛和生理痛,令人放松、稳定情绪,也适合用来改善失眠,是天然的镇定剂,松弛、镇定神经效果特佳;还对平滑肌有镇定作用,可放松过度紧张的肌肉,使其达到充分的休息,具有稳定情绪、预防失眠的优异效果。
朝鲜蓟根:根部可作为药物,有增强肝脏机能的功效。
白豆蔻:味辛、性温,归肺、脾、胃经,功效化湿,行气,温中;王好古:"补肺气,益脾胃,理元气,收脱气。"
金钱薄荷:是一种匍匐性草本植物,颜色较浅绿,能食用,能药用,性辛、微苦,性凉,活血止血,清肺热,散血热;治痛经,月经不调。
金丝桃根:根能祛风、止咳、下乳、调经补血;但有小毒,只能采用少量。
本发明具有以下有益效果:
本发明药物组合物在美容养颜活血调经方面具有显著的疗效,能有效的补肾、扶脾、疏肝、调理气血,有效治疗各种月经病,标本兼治,同时达到美容养颜的效果,调理女性身体;并且通过本发明药方君臣佐使诸药配合,协同促进,相辅相成,使得药效更好,药物的疗效更加全面,且不易反复,无副作用,没有任何西药或者激素药成分,可以作为临床的药物使用。
除了上面所描述的目的、特征和优点之外,本发明还有其它的目的、特征和优点。下面将对本发明作进一步详细的说明。
具体实施方式
以下对本发明的实施例进行详细说明,但是本发明可以根据权利要求限定和覆盖的多种不同方式实施。
实施例1:
本发明实施例1药物组合物的制备原料包括:鹰嘴豆异黄酮15份、大豆异黄酮12份、罗勒10份、荷包牡丹10份、刺五加15份、当归15份、白花苋15份、素馨花13份、覆盘子9份、番红花6份、柠檬汁6份、积雪草6份、金盏花6份、黄金菊6份、朝鲜蓟根6份、金钱薄荷6份、金丝桃根2份和甘草8份。
制备方法如下:
(1)制备鹰嘴豆异黄酮:将鹰嘴豆用水浸泡,在10-20℃下发芽处理3-5天,分离出胚芽,在40-50℃下烘干,粉碎,加入20-50质量倍的体积浓度为55%-85%的乙醇水溶液,混合,在超声功率200-500W条件下,超声10-30min,在水浴温度60-80℃下加热1-2h提取,分离,提取1-6次,合并提取液并过滤,滤液旋转除尽乙醇,得到粗提液;将粗提液装入大孔树脂柱,静置1-3h,先用体积浓度为10%-20%的乙醇水溶液洗去杂质,再用体积浓度为60%-90%乙醇水溶液洗脱,洗脱流速为0.5-2mL/min,收集洗脱液,旋转蒸发,除尽乙醇,得到浓缩液,真空冷冻干燥,得到黄色粉末鹰嘴豆异黄酮;
(2)制备大豆异黄酮:将大豆磨碎并进行发酵处理;将大豆的发酵液放入陶瓷膜中膜进行过滤处理,将其中有的菌体、菌落、菌丝体、不可溶型蛋白以及可溶性大分子蛋白等杂质去除,得到微滤透析液;将微滤透析液放入有机脱色膜系统进行脱色处理,然后调节PH后进行浓缩处理,得到大豆异黄酮浓缩液,将大豆异黄酮浓缩液再次调节PH,除去其中可溶蛋白质,最后进行浓缩结晶处理,得到大豆异黄酮结晶块;将得到的大豆异黄酮结晶块放入乙醇后进行润洗处理,然后进行完全干燥处理,得到干燥的大豆异黄酮结晶块,研磨粉碎,得到大豆异黄酮;
(3)称取罗勒、刺五加、当归、覆盘子、朝鲜蓟根和金丝桃根,粉碎,混合均匀,备用;
(4)往步骤(3)中药粉加入药粉重量6-8倍浓度为60%-70%的乙醇溶液,回流提取1-3次,回流时间为1-2h,合并滤液,保留滤渣,滤液回收乙醇,减压浓缩至55-60℃环境下相对密度为1.20-1.25的浸膏,减压干燥,粉碎后过80-100目筛,得到浸膏细粉;
(5)称取荷包牡丹、白花苋、素馨花、番红花、积雪草、金盏花、黄金菊、金钱薄荷和甘草,粉碎,混合均匀,备用;
(6)取步骤(5)中药粉,加入步骤(4)中的滤渣,混合,得到混合物,加入混合物重量4-6倍的蒸馏水,浸泡1-2小时,回流煎煮1-2小时,过滤,再加入混合物重量3-4倍的蒸馏水,回流煎煮0.5-1小时,过滤,合并滤液,减压浓缩至55-60℃环境下相对密度为1.20-1.25的浸膏,加入柠檬汁,减压干燥,粉碎后过80-100目筛,得到浸膏细粉;
(7)将鹰嘴豆异黄酮、大豆异黄酮与步骤(4)中浸膏细粉和步骤(6)中浸膏细粉混合,搅拌均匀,即得本发明药物组合物。
实施例2:
本发明实施例2药物组合物的制备原料包括:鹰嘴豆异黄酮20份、大豆异黄酮18份、罗勒18份、荷包牡丹18份、刺五加20份、当归20份、白花苋20份、素馨花18份、覆盘子12份、番红花10份、柠檬汁9份、积雪草12份、金盏花12份、黄金菊9份、朝鲜蓟根9份、金钱薄荷10份、金丝桃根5份和甘草20份。
制备方法同实施例1。
实施例3:
本发明实施例3药物组合物的制备原料包括:鹰嘴豆异黄酮18份、大豆异黄酮15份、罗勒14份、荷包牡丹14份、刺五加18份、当归18份、白花苋18份、素馨花15份、覆盘子10份、番红花8份、柠檬汁8份、积雪草9份、金盏花9份、黄金菊8份、朝鲜蓟根8份、金钱薄荷8份、金丝桃根3份和甘草14份。
制备方法同实施例1。
实施例4:
本发明药物组合物对大鼠雌激素水平影响实验
1、实验方法:取60只雌性SD大鼠,随机分为5组,每组12只,分别为空白对照组、模型组、低剂量组、中剂量组和高剂量组,除空白对照组外,对其他各组大鼠做双侧卵巢切除术,术后3个月,给各组大鼠灌胃给药,空白对照组和模型组灌胃等量的生理盐水,低剂量组、中剂量组和高剂量组灌胃相应的药物,所用药物为实施例3制备得到的药物组合物,每天一次,连续给药30天。末次给药2小时后,腹动脉取血制备血清,用试剂盒检测血清雌二醇(E2)和促卵泡素(FSH)含量,进行组间比较。
2、实验结果:如表1所示。
表1实验结果
注:与模型组相比,▲P<0.05,与空白对照组相比,★★P<0.01。
由表1可知,与空白对照组相比,模型组促卵泡素和血清雌二醇显著降低,具有极显著的差异;与模型组相比,高、中、低剂量组的促卵泡素和血清雌二醇有比较显著的提高,具有显著性的差异,可见,本发明药物组合物能够明显升高大鼠血清雌二醇和促卵泡素含量,对大鼠雌激素有一定的升高作用。
由于雌性激素与月经是否正常有紧密联系,因此雌性激素的多少都会对月经的正常产生影响,通过本实验对大鼠雌激素的影响,可以得知本发明药物组合物在控制雌激素方面具有一定的作用,实验结果显示,本发明药物组合物对大鼠雌激素有一定的升高作用,可见,本发明药物组合物在治疗月经不调方面具有显著的疗效。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种美容养颜活血调经的药物组合物,其特征在于,所述的药物组合物包括以下重量份数的制备原料:
鹰嘴豆异黄酮15-20份、大豆异黄酮12-18份、罗勒 10-18份、荷包牡丹10-18份、刺五加15-20份、当归15-20份、白花苋15-20份、素馨花13-18份、覆盘子9-12份、番红花6-10份、柠檬汁6-9份、积雪草6-12份、金盏花6-12份、黄金菊6-9份、朝鲜蓟根6-9份、金钱薄荷6-10份、金丝桃根2-5份和甘草8-20份。
2.根据权利要求1所述的用于美容养颜活血调经的药物组合物,其特征在于,所述的药物组合物包括以下重量份数的制备原料:
鹰嘴豆异黄酮15份、大豆异黄酮12份、罗勒 10份、荷包牡丹10份、刺五加15份、当归15份、白花苋15份、素馨花13份、覆盘子9份、番红花6份、柠檬汁6份、积雪草6份、金盏花6份、黄金菊6份、朝鲜蓟根6份、金钱薄荷6份、金丝桃根2份和甘草8份。
3.根据权利要求1所述的用于美容养颜活血调经的药物组合物,其特征在于,所述的药物组合物包括以下重量份数的制备原料:
鹰嘴豆异黄酮20份、大豆异黄酮18份、罗勒 18份、荷包牡丹18份、刺五加20份、当归20份、白花苋20份、素馨花18份、覆盘子12份、番红花10份、柠檬汁9份、积雪草12份、金盏花12份、黄金菊9份、朝鲜蓟根9份、金钱薄荷10份、金丝桃根5份和甘草20份。
4.根据权利要求1所述的用于美容养颜活血调经的药物组合物,其特征在于,所述的药物组合物包括以下重量份数的制备原料:
鹰嘴豆异黄酮18份、大豆异黄酮15份、罗勒 14份、荷包牡丹14份、刺五加18份、当归18份、白花苋18份、素馨花15份、覆盘子10份、番红花8份、柠檬汁8份、积雪草9份、金盏花9份、黄金菊8份、朝鲜蓟根8份、金钱薄荷8份、金丝桃根3份和甘草14份。
5.根据权利要求1所述的用于美容养颜活血调经的药物组合物,其特征在于,所述鹰嘴豆异黄酮的制备方法步骤如下:
步骤一:将鹰嘴豆用水浸泡,在10-20℃下发芽处理3-5天,分离出胚芽,在40-50℃下烘干, 粉碎,加入20-50质量倍的体积浓度为55%-85%的乙醇水溶液,混合,在超声功率200-500W条件下,超声10-30min,在水浴温度60-80℃下加热1-2h提取,分离,提取1-6次,合并提取液并过滤,滤液旋转除尽乙醇,得到粗提液;
步骤二:将粗提液装入大孔树脂柱,静置1-3h,先用体积浓度为10%-20%的乙醇水溶液洗去杂质,再用体积浓度为60%-90%乙醇水溶液洗脱,洗脱流速为0 .5-2mL/min,收集洗脱液,旋转蒸发,除尽乙醇,得到浓缩液,真空冷冻干燥,得到黄色粉末鹰嘴豆异黄酮。
6.根据权利要求5所述的用于美容养颜活血调经的药物组合物,其特征在于,步骤二所述大孔树脂的型号为AB-8、DM-130、DM301、D101、HP-100、XAD-2或HP-20型。
7.根据权利要求1所述的用于美容养颜活血调经的药物组合物,其特征在于,所述大豆异黄酮的制备方法包括以下步骤:
步骤一:将大豆磨碎并进行发酵处理;
步骤二:将大豆的发酵液放入陶瓷膜中膜进行过滤处理,将其中有的菌体、菌落、菌丝体、不可溶型蛋白以及可溶性大分子蛋白等杂质去除,得到微滤透析液;
步骤三:将微滤透析液放入有机脱色膜系统进行脱色处理,然后调节PH后进行浓缩处理,得到大豆异黄酮浓缩液,将大豆异黄酮浓缩液再次调节PH,除去其中可溶蛋白质,最后进行浓缩结晶处理,得到大豆异黄酮结晶块;
步骤四:将得到的大豆异黄酮结晶块放入乙醇后进行润洗处理,然后进行完全干燥处理,得到干燥的大豆异黄酮结晶块,研磨粉碎,得到大豆异黄酮。
8.根据权利要求7所述的用于美容养颜活血调经的药物组合物,其特征在于,所述步骤三中通过柠檬酸和氢氧化钠对微滤透析液和大豆异黄酮浓缩液进行PH调节。
9.根据权利要求1-8任一项所述的用于美容养颜活血调经的药物组合物,其特征在于,所述药物组合物被制成胶囊剂,滴丸剂,散剂,口服液,片剂和颗粒剂。
10.根据权利要求9所述的用于美容养颜活血调经的药物组合物的制备方法,其特征在于,所述药物组合物的制备方法包含下述步骤:
1)称取罗勒、刺五加、当归、覆盘子、朝鲜蓟根和金丝桃根,粉碎,混合均匀,备用;
2)往步骤1)中药粉加入药粉重量6-8倍浓度为60%-70%的乙醇溶液,回流提取1-3次,回流时间为1-2h,合并滤液,保留滤渣,滤液回收乙醇,减压浓缩至55-60℃环境下相对密度为1.20-1.25的浸膏,减压干燥,粉碎后过80-100目筛,得到浸膏细粉;
3)称取荷包牡丹、白花苋、素馨花、番红花、积雪草、金盏花、黄金菊、金钱薄荷和甘草,粉碎,混合均匀,备用;
4)取步骤3)中药粉,加入步骤2)中的滤渣,混合,得到混合物,加入混合物重量4-6倍的蒸馏水,浸泡1-2小时,回流煎煮1-2小时,过滤,再加入混合物重量3-4倍的蒸馏水,回流煎煮0.5-1小时,过滤,合并滤液,减压浓缩至55-60℃环境下相对密度为1.20-1.25的浸膏,加入柠檬汁,减压干燥,粉碎后过80-100目筛,得到浸膏细粉;
5)将鹰嘴豆异黄酮、大豆异黄酮与步骤2)中浸膏细粉和步骤4)中浸膏细粉混合,搅拌均匀,即得本发明药物组合物。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710375035.7A CN107198727A (zh) | 2017-05-24 | 2017-05-24 | 一种美容养颜活血调经的药物组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710375035.7A CN107198727A (zh) | 2017-05-24 | 2017-05-24 | 一种美容养颜活血调经的药物组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107198727A true CN107198727A (zh) | 2017-09-26 |
Family
ID=59905801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710375035.7A Pending CN107198727A (zh) | 2017-05-24 | 2017-05-24 | 一种美容养颜活血调经的药物组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107198727A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107927779A (zh) * | 2017-11-27 | 2018-04-20 | 爱可道生物科技有限公司 | 一种美容养颜口服液及其制备方法 |
| CN110897952A (zh) * | 2019-12-03 | 2020-03-24 | 朱建康 | 一种朝鲜蓟根提取物的制备方法及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104984297A (zh) * | 2015-07-24 | 2015-10-21 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种药物组合物在制备治疗闭经药物中的用途 |
| CN106282258A (zh) * | 2016-09-24 | 2017-01-04 | 合肥信达膜科技有限公司 | 一种大豆异黄酮分离技术 |
| CN106361801A (zh) * | 2016-08-27 | 2017-02-01 | 天津大学 | 一种鹰嘴豆异黄酮分离纯化方法 |
-
2017
- 2017-05-24 CN CN201710375035.7A patent/CN107198727A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104984297A (zh) * | 2015-07-24 | 2015-10-21 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种药物组合物在制备治疗闭经药物中的用途 |
| CN106361801A (zh) * | 2016-08-27 | 2017-02-01 | 天津大学 | 一种鹰嘴豆异黄酮分离纯化方法 |
| CN106282258A (zh) * | 2016-09-24 | 2017-01-04 | 合肥信达膜科技有限公司 | 一种大豆异黄酮分离技术 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107927779A (zh) * | 2017-11-27 | 2018-04-20 | 爱可道生物科技有限公司 | 一种美容养颜口服液及其制备方法 |
| CN110897952A (zh) * | 2019-12-03 | 2020-03-24 | 朱建康 | 一种朝鲜蓟根提取物的制备方法及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104435775A (zh) | 一种中药保健酒及其制备方法 | |
| CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
| CN103041208B (zh) | 一种治疗妇女更年期综合征的中药制剂及其制备方法 | |
| CN105496917A (zh) | 一种积雪草抗皱面霜及其制备方法 | |
| CN104305205B (zh) | 一种提高免疫力的菟丝子口服液及其制备方法 | |
| CN101485786B (zh) | 一种美白祛斑组合物及其制备方法 | |
| CN108887544A (zh) | 一种天然养生饮料 | |
| CN107198727A (zh) | 一种美容养颜活血调经的药物组合物及其制备方法 | |
| CN103054073B (zh) | 一种养颜鱼鳞冻及其制备方法 | |
| CN102178781A (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
| CN114712466B (zh) | 一种具有减肥养颜功效的药物及其制备方法 | |
| CN105435197A (zh) | 一种治疗桥本氏病的药物组合物及其制备方法 | |
| CN104398734B (zh) | 一种补血养颜的桑寄生口服液及其制备方法 | |
| CN104043058A (zh) | 一种治疗肾虚型腰椎间盘突出的中药制剂及其制备方法 | |
| CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
| CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
| CN104432386B (zh) | 一种防治腰膝酸软、筋骨无力的桑寄生口服液及其制备方法 | |
| CN107753602A (zh) | 一种治疗白血病的中药组合物及其制备方法 | |
| CN102091254B (zh) | 一种用于面部整容后消肿的中药组合物及其制备方法 | |
| CN105362630A (zh) | 一种治疗更年期综合症的药物组合物及其制备方法 | |
| CN105362629A (zh) | 一种含有杜仲的治疗女性更年期综合症的药物组合物及其制备方法 | |
| CN104689125A (zh) | 一种治疗沙眼的药物及其制备方法 | |
| CN104983886A (zh) | 治疗便秘的中药制剂及制备方法 | |
| CN114712470B (zh) | 一种治疗男士肾亏的药物及其制备方法 | |
| CN106692690A (zh) | 一种治疗青少年白发的药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170926 |